{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T15:23:00Z","timestamp":1774452180155,"version":"3.50.1"},"reference-count":39,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82404671"],"award-info":[{"award-number":["82404671"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81872170"],"award-info":[{"award-number":["81872170"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82103199"],"award-info":[{"award-number":["82103199"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Natural Science Foundation of China-Zhejiang Joint Fund","award":["U20A20382"],"award-info":[{"award-number":["U20A20382"]}]},{"name":"Zhejiang Province Ten Thousand Talents Plan Outstanding Talent Project","award":["2022R51002"],"award-info":[{"award-number":["2022R51002"]}]},{"name":"Zhejiang Medical and Health Science and Technology Project","award":["2024KY1267"],"award-info":[{"award-number":["2024KY1267"]}]},{"name":"Project of Wenzhou research","award":["Y2023151"],"award-info":[{"award-number":["Y2023151"]}]},{"name":"Project of Wenzhou research","award":["ZY2023024"],"award-info":[{"award-number":["ZY2023024"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>This study assessed CLDN16 as a potential replacement or improvement biomarker for papillary thyroid cancer (PTC), addressing the limitations associated with the prevalently used BRAF-V600E mutation.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Design<\/jats:title>\n                  <jats:p>Database analyses, tissue validation, RNA sequencing, and functional assays were conducted to evaluate CLDN16 as a PTC biomarker and its clinical application.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>CLDN16 expression was examined in PTC and normal thyroid\/para-tumor tissues and compared across various cancer types. We evaluated diagnostic accuracy, stability in primary and metastatic sites, and associations with aggressive features. Knockdown experiments were performed to investigate the impact on PTC cell behavior. Additionally, we developed a support vector machine model for diagnosing malignant and high-risk PTCs.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>CLDN16 demonstrated high specificity for PTC, with positive detection rates (88.0% in The Cancer Genome Atlas [TCGA] and 88.3% in our center) significantly surpassing BRAF-V600E (47.5% in TCGA and 74.3% in our center). This resulted in superior diagnostic accuracy (ROC-CLDN16 = 0.922 vs ROC-BRAF-V600E = 0.742 in TCGA). CLDN16 exhibited stable expression across primary and metastatic sites and was associated with aggressive features, including extrathyroidal extension and lymph node metastasis. CLDN16 knockdown inhibited migration, invasion, and iodine uptake in PTC cells. Clinically, CLDN16 effectively identified malignancy in BRAF wild patients (94.2%), and combined with BRAF-V600E, achieved 96.9% accuracy. The incorporation of CLDN16 into PTC molecular typing facilitated precise high-risk identification (92.0% accuracy in the training set and 100% in the validation set).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>CLDN16 presents a promising biomarker that could surpass BRAF-V600E, offering effective clinical utility and revolutionizing PTC molecular typing for precise high-risk identification.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/ejendo\/lvaf003","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:02:06Z","timestamp":1740477726000},"page":"128-140","source":"Crossref","is-referenced-by-count":2,"title":["A new broom sweeps clean: CLDN16 surpasses the BRAF-V600E mutation as an unrivaled biomarker in papillary thyroid cancer"],"prefix":"10.1093","volume":"192","author":[{"given":"Yefeng","family":"Cai","sequence":"first","affiliation":[{"name":"Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College , Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Department of Thyroid Surgery, National Key Clinical Specialty (General Surgery), The First Affiliated Hospital of Wenzhou Medical University , Wenzhou, Zhejiang 325000 ,","place":["China"]},{"name":"Department of Public Health, Zhejiang University School of Medicine , Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer , Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Provincial Clinical Research Center for Head & Neck Cancer , Zhengjiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yawen","family":"Guo","sequence":"additional","affiliation":[{"name":"Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College , Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer , Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Provincial Clinical Research Center for Head & Neck Cancer , Zhengjiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenli","family":"Ma","sequence":"additional","affiliation":[{"name":"Graduate School, Bengbu Medical University , Bengbu, Anhui 233030 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Second Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou, Zhejiang 310003 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liehao","family":"Jiang","sequence":"additional","affiliation":[{"name":"Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College , Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer , Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Provincial Clinical Research Center for Head & Neck Cancer , Zhengjiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuyan","family":"Shen","sequence":"additional","affiliation":[{"name":"Second Clinical Medical College, Zhejiang Chinese Medical University , Hangzhou, Zhejiang 310053 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahuan","family":"Song","sequence":"additional","affiliation":[{"name":"Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer , Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Provincial Clinical Research Center for Head & Neck Cancer , Zhengjiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Department of Nuclear Medicine, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College , Hangzhou, Zhejiang 310014 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thyroid Surgery, The Fifth Hospital Affiliated to Wenzhou Medical University, Lishui Central Hospital , Lishui City, Zhejiang 323000 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiqun","family":"Hu","sequence":"additional","affiliation":[{"name":"Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College , Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer , Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Provincial Clinical Research Center for Head & Neck Cancer , Zhengjiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou, Zhejiang 325000 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanting","family":"Duan","sequence":"additional","affiliation":[{"name":"Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College , Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer , Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiujun","family":"Cai","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine, Zhejiang University , Hangzhou 310058 ,","place":["China"]},{"name":"Department of General Surgery, Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine , Hangzhou, Zhejiang 310016 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Breast Surgery, The First Affiliated Hospital of Wenzhou Medical University , Wenzhou, Zhejiang 325000 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guowan","family":"Zheng","sequence":"additional","affiliation":[{"name":"Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College , Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer , Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Provincial Clinical Research Center for Head & Neck Cancer , Zhengjiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6726-6418","authenticated-orcid":false,"given":"Minghua","family":"Ge","sequence":"additional","affiliation":[{"name":"Otolaryngology & Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College , Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Key Laboratory of Precision Medicine Research on Head & Neck Cancer , Zhejiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]},{"name":"Zhejiang Provincial Clinical Research Center for Head & Neck Cancer , Zhengjiang Provincial People's Hospital, Hangzhou, Zhejiang 310014 ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,2,25]]},"reference":[{"issue":"5","key":"2025022510015540400_lvaf003-B1","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3322\/caac.21731","article-title":"Cancer treatment and survivorship statistics, 2022","volume":"72","author":"Miller","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2025022510015540400_lvaf003-B2","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S2213-8587(22)00035-3","article-title":"The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020","volume":"10","author":"Pizzato","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"2025022510015540400_lvaf003-B3","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"4","key":"2025022510015540400_lvaf003-B4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1530\/ERC-15-0445","article-title":"Recent incidences and differential trends of thyroid cancer in the USA","volume":"23","author":"Mao","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"2025022510015540400_lvaf003-B5","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","author":"Cancer Genome Atlas Research Network","year":"2014","journal-title":"Cell"},{"issue":"5","key":"2025022510015540400_lvaf003-B6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.21037\/gs.2016.09.09","article-title":"BRAF V600E mutation in prognostication of papillary thyroid cancer (PTC) recurrence","volume":"5","author":"Czarniecka","year":"2016","journal-title":"Gland Surg"},{"issue":"7","key":"2025022510015540400_lvaf003-B7","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1210\/er.2007-0007","article-title":"BRAF mutation in papillary thyroid cancer: pathogenic role, molecular bases, and clinical implications","volume":"28","author":"Xing","year":"2007","journal-title":"Endocr Rev"},{"issue":"2","key":"2025022510015540400_lvaf003-B8","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1677\/erc.1.0978","article-title":"BRAF mutation in thyroid cancer","volume":"12","author":"Xing","year":"2005","journal-title":"Endocr Relat Cancer"},{"issue":"11","key":"2025022510015540400_lvaf003-B9","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1210\/clinem\/dgab286","article-title":"BRAF V600E status sharply differentiates lymph node metastasis-associated mortality risk in papillary thyroid cancer","volume":"106","author":"Tao","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"issue":"25","key":"2025022510015540400_lvaf003-B10","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","article-title":"BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence","volume":"32","author":"Xing","year":"2014","journal-title":"J Clin Oncol"},{"issue":"1","key":"2025022510015540400_lvaf003-B11","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1200\/JCO.2014.56.8253","article-title":"Association between BRAF V600E mutation and recurrence of papillary thyroid cancer","volume":"33","author":"Xing","year":"2015","journal-title":"J Clin Oncol"},{"issue":"5","key":"2025022510015540400_lvaf003-B12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1200\/JCO.2017.74.5497","article-title":"Patient age-associated mortality risk is differentiated by BRAF V600E status in papillary thyroid cancer","volume":"36","author":"Shen","year":"2018","journal-title":"J Clin Oncol"},{"issue":"24","key":"2025022510015540400_lvaf003-B13","doi-asserted-by":"publisher","first-page":"15626","DOI":"10.3390\/ijms232415626","article-title":"Association of BRAF(V600E) mutation with the aggressive behavior of papillary thyroid microcarcinoma: a meta-analysis of 33 studies","volume":"23","author":"Attia","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"4","key":"2025022510015540400_lvaf003-B14","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/PAT.0b013e328360b61d","article-title":"Clinicopathological relevance of BRAF mutations in human cancer","volume":"45","author":"Pakneshan","year":"2013","journal-title":"Pathology"},{"issue":"1","key":"2025022510015540400_lvaf003-B15","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3803\/EnM.2020.35.1.44","article-title":"Recent improvements in genomic and transcriptomic understanding of anaplastic and poorly differentiated thyroid cancers","volume":"35","author":"Yoo","year":"2020","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"3","key":"2025022510015540400_lvaf003-B16","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"issue":"1","key":"2025022510015540400_lvaf003-B17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s12022-022-09707-3","article-title":"Overview of the 2022 WHO classification of thyroid neoplasms","volume":"33","author":"Baloch","year":"2022","journal-title":"Endocr Pathol"},{"issue":"11","key":"2025022510015540400_lvaf003-B18","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"2025022510015540400_lvaf003-B19","doi-asserted-by":"publisher","first-page":"1252389","DOI":"10.3389\/fendo.2023.1252389","article-title":"Global research landscape and trends of papillary thyroid cancer therapy: a bibliometric analysis","volume":"14","author":"Song","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 1","key":"2025022510015540400_lvaf003-B20","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.21037\/gs.2017.11.07","article-title":"Molecular testing in the diagnosis of differentiated thyroid carcinomas","volume":"7","author":"Ferrari","year":"2018","journal-title":"Gland Surg"},{"issue":"12","key":"2025022510015540400_lvaf003-B21","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1089\/thy.2009.0240","article-title":"Molecular diagnostics and predictors in thyroid cancer","volume":"19","author":"Nikiforova","year":"2009","journal-title":"Thyroid"},{"issue":"8","key":"2025022510015540400_lvaf003-B22","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.3390\/cancers12082164","article-title":"Molecular markers guiding thyroid cancer management","volume":"12","author":"Nylen","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"12","key":"2025022510015540400_lvaf003-B23","doi-asserted-by":"publisher","first-page":"3311","DOI":"10.1210\/clinem\/dgad335","article-title":"The diagnostic efficacy of FNA-Tg in DTC cervical LN metastasis and its impact factors: a large retrospective study","volume":"108","author":"Liu","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2025022510015540400_lvaf003-B24","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1002\/hed.25488","article-title":"Superior detection of metastatic cystic lymphadenopathy in patients with papillary thyroid cancer by utilization of thyroglobulin washout","volume":"41","author":"Khadra","year":"2019","journal-title":"Head Neck"},{"issue":"2","key":"2025022510015540400_lvaf003-B25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3348\/kjr.2009.10.2.106","article-title":"Diagnostic benefit of thyroglobulin measurement in fine-needle aspiration for diagnosing metastatic cervical lymph nodes from papillary thyroid cancer: correlations with US features","volume":"10","author":"Jeon","year":"2009","journal-title":"Korean J Radiol"},{"issue":"1","key":"2025022510015540400_lvaf003-B26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1089\/thy.2013.0244","article-title":"Thyroglobulin in the washout fluid of lymph-node biopsy: what is its role in the follow-up of differentiated thyroid carcinoma?","volume":"24","author":"Torres","year":"2014","journal-title":"Thyroid"},{"issue":"3","key":"2025022510015540400_lvaf003-B27","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3803\/EnM.2019.34.3.215","article-title":"Radioactive iodine-refractory differentiated thyroid cancer and redifferentiation therapy","volume":"34","author":"Liu","year":"2019","journal-title":"Endocrinol Metab (Seoul)"},{"issue":"4","key":"2025022510015540400_lvaf003-B28","doi-asserted-by":"publisher","first-page":"188928","DOI":"10.1016\/j.bbcan.2023.188928","article-title":"Molecular basis and targeted therapy in thyroid cancer: progress and opportunities","volume":"1878","author":"Zhang","year":"2023","journal-title":"Biochim Biophys Acta Rev Cancer"},{"issue":"1091","key":"2025022510015540400_lvaf003-B29","doi-asserted-by":"publisher","first-page":"20180136","DOI":"10.1259\/bjr.20180136","article-title":"Differentiated thyroid cancer theranostics: radioiodine and beyond","volume":"91","author":"Choudhury","year":"2018","journal-title":"Br J Radiol"},{"issue":"6","key":"2025022510015540400_lvaf003-B30","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1177\/1758834014548188","article-title":"Treatment strategies for radioactive iodine-refractory differentiated thyroid cancer","volume":"6","author":"Worden","year":"2014","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"2025022510015540400_lvaf003-B31","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s40364-022-00385-1","article-title":"Claudin18.2 is a novel molecular biomarker for tumor-targeted immunotherapy","volume":"10","author":"Cao","year":"2022","journal-title":"Biomark Res"},{"issue":"6","key":"2025022510015540400_lvaf003-B32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1038\/s41591-022-01800-8","article-title":"Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results","volume":"28","author":"Qi","year":"2022","journal-title":"Nat Med"},{"issue":"9","key":"2025022510015540400_lvaf003-B33","doi-asserted-by":"publisher","first-page":"4087","DOI":"10.1210\/jc.2019-00177","article-title":"Risk stratification in differentiated thyroid cancer: from detection to final follow-up","volume":"104","author":"Tuttle","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"2025022510015540400_lvaf003-B34","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.21037\/gs-21-105","article-title":"The incidence of postoperative re-stratification for recurrence in well-differentiated thyroid cancer-a retrospective cohort study","volume":"10","author":"Carmel Neiderman","year":"2021","journal-title":"Gland Surg"},{"issue":"1","key":"2025022510015540400_lvaf003-B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"2025022510015540400_lvaf003-B36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.7150\/jca.2.193","article-title":"Thyroid cancer: burden of illness and management of disease","volume":"2","author":"Brown","year":"2011","journal-title":"J Cancer"},{"issue":"5","key":"2025022510015540400_lvaf003-B37","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/0002-9343(94)90321-2","article-title":"Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer","volume":"97","author":"Mazzaferri","year":"1994","journal-title":"Am J Med"},{"key":"2025022510015540400_lvaf003-B38","doi-asserted-by":"publisher","first-page":"923182","DOI":"10.3389\/fendo.2022.923182","article-title":"Outcomes of patients with metastatic differentiated thyroid cancer after excellent response to treatment","volume":"13","author":"Hsu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2025022510015540400_lvaf003-B39","volume-title":"Evidence Review for Efficacy of Repeat Fine Needle Aspiration Cytology, Active Surveillance or Discharge: Thyroid Cancer: Assessment and Management","author":"NICE Evidence Reviews Collection","year":"2022"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/2\/128\/62164604\/lvaf003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ejendo\/article-pdf\/192\/2\/128\/62164604\/lvaf003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T10:02:22Z","timestamp":1740477742000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/192\/2\/128\/8041908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,1]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ejendo\/lvaf003","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,2]]},"published":{"date-parts":[[2025,2,1]]}}}